Skip to content

Drug interactions

Rizatriptan + Tranylcypromine

Severity: Contraindicated

Rizatriptan and Tranylcypromine: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tranylcypromine inhibits MAO-A, the main enzyme that clears rizatriptan, so rizatriptan exposure rises substantially. The combination also adds serotonergic activity, raising the risk of serotonin syndrome and vasoconstrictive effects. Labeling contraindicates use during and for 2 weeks after MAOI therapy.

What this interaction means in plain words

Rizatriptan and Tranylcypromine are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Rizatriptan belongs to Central Nervous System; Tranylcypromine belongs to Central Nervous System.

Evidence level: High

Why it happens

Nonselective irreversible MAO inhibition blocks the MAO-A-mediated metabolism of rizatriptan and adds serotonergic effects.

What to do

Do not co-administer, and do not give rizatriptan within 2 weeks of stopping tranylcypromine. Use a non-serotonergic acute migraine option and manage blood pressure and headache with the prescriber's guidance.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Rizatriptan and Tranylcypromine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Rizatriptan with Tranylcypromine?

MediHelp rates the interaction as contraindicated. Rizatriptan and Tranylcypromine are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Tranylcypromine inhibits MAO-A, the main enzyme that clears rizatriptan, so rizatriptan exposure rises substantially. The combination also adds serotonergic activity, raising the risk of serotonin syndrome and vasoconstrictive effects. Labeling contraindicates use during and for 2 weeks after MAOI therapy.

How serious is the interaction between Rizatriptan and Tranylcypromine?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not co-administer, and do not give rizatriptan within 2 weeks of stopping tranylcypromine. Use a non-serotonergic acute migraine option and manage blood pressure and headache with the prescriber's guidance.

What other medicines interact with Tranylcypromine?

MediHelp also lists interactions of Tranylcypromine with, for example, 5-HTP, Amitriptyline, Amoxapine. The full list is on the Tranylcypromine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in